Integrating Scenario Planning and Cost-Benefit Methods
- PMID: 29453844
- DOI: 10.1002/hast.821
Integrating Scenario Planning and Cost-Benefit Methods
Abstract
By their nature, the most vexing social problems reflect collisions between social and economic interests of parties with highly divergent views and perspectives on the cause and character of what is at issue and the consequences that flow from it. Conflicts around biotechnology applications are good examples of these problems. When considering the potential consequences of proposed biotechnology applications, an enormous range of perspectives arise reflecting the breadth of different and often competing interests with a stake in life's future. This essay starts from an assumption that the traditional tool of cost-benefit analysis is not adequate for adjudicating competing claims around the introduction of new biotechnology applications. It tends to require implicit simplifying assumptions that reduce or mask true underlying levels of complexity and uncertainty, and the results it produces deliver a definitive and singular answer, as opposed to a multiplicity of outcomes. In this essay, I describe some of the key elements of formal scenario planning to show how CBA could be redeployed as a supporting tool within the broader decision support methodology of formal scenario planning.
© 2018 The Hastings Center.
Similar articles
-
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x. Value Health. 2007. PMID: 17888098
-
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13. Value Health. 2014. PMID: 24438712
-
CBA and Precaution: Policy-Making about Emerging Technologies.Hastings Cent Rep. 2018 Jan;48 Suppl 1:S88-S96. doi: 10.1002/hast.824. Hastings Cent Rep. 2018. PMID: 29453836
-
Benefit-Cost Analysis and Emerging Technologies.Hastings Cent Rep. 2018 Jan;48 Suppl 1:S12-S20. doi: 10.1002/hast.817. Hastings Cent Rep. 2018. PMID: 29453837
-
Cost-benefit studies of health care programs. Choosing methods for desired results.Eval Health Prof. 1984 Sep;7(3):285-303. doi: 10.1177/016327878400700302. Eval Health Prof. 1984. PMID: 10310840 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources